Andrei Alexandrescu

Dr. Andrei Alexandrescu

Molecular & Cell Biology, University of Connecticut, BSP 209, 91 North Eagleville Road, Unit 3125, Storrs, CT 06269-3125, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SPSharadrao M. Patil
Sharadrao M. Patil
SXShihao Xu
Shihao Xu
SSSarah R. Sheftic
Sarah R. Sheftic
AAAndrei Alexandrescu
Andrei Alexandrescu
Amylin is an endocrine hormone that regulates metabolism. In patients afflicted with type 2 diabetes, amylin is found in fibrillar deposits in the pancreas. Membranes are thought to facilitate the aggregation of amylin, and membrane-bound oligomers may be responsible for the islet β-cell toxicity that develops during type 2 diabetes. To better understand the structural basis for the interactions between amylin and membranes, we determined the NMR structure of human amylin bound to SDS micelles. The first four residues in the structure are constrained to form a hairpin loop by the single disulfide bond in amylin. The last nine residues near the C terminus are unfolded. The core of the structure is an α-helix that runs from about residues 5–28. A distortion or kink near residues 18–22 introduces pliancy in the angle between the N- and C-terminal segments of the α-helix. Mobility, as determined by 15N relaxation experiments, increases from the N to the C terminus and is strongly correlated with the accessibility of the polypeptide to spin probes in the solution phase. The spin probe data suggest that the segment between residues 5 and 17 is positioned within the hydrophobic lipid environment, whereas the amyloidogenic segment between residues 20 and 29 is at the interface between the lipid and solvent. This orientation may direct the aggregation of amylin on membranes, whereas coupling between the two segments may mediate the transition to a toxic structure.

8 January 2014 in Biochemistry
Verified
Journal Article
Closed access
SJSuman Jha
Suman Jha
JSJessica M. Snell
Jessica M. Snell
SSSarah R. Sheftic
Sarah R. Sheftic
SPSharadrao M. Patil
Sharadrao M. Patil
SDStephen B. Daniels
Stephen B. Daniels
AAAndrei Alexandrescu
Andrei Alexandrescu

1 January 2005 in Protein Science
Verified
Journal Article
Closed access
PDF file
AAAndrei Alexandrescu
Andrei Alexandrescu

1 August 2008 in Protein Science
Verified
Journal Article
Closed access
PDF file
RCRobyn L. Croke
Robyn L. Croke
CSChristine O. Sallum
Christine O. Sallum
EWEmma Watson
Emma Watson
EWEric D. Watt
Eric D. Watt
AAAndrei Alexandrescu
Andrei Alexandrescu

16 November 2010 in Protein Science
Verified
Journal Article
Open access
PDF file
RCRobyn L. Croke
Robyn L. Croke
SPSharadrao M. Patil
Sharadrao M. Patil
JQJason Quevreaux
Jason Quevreaux
DKDebra A. Kendall
Debra A. Kendall
AAAndrei Alexandrescu
Andrei Alexandrescu
The intrinsically unfolded protein α‐synuclein has an N‐terminal domain with seven imperfect KTKEGV sequence repeats and a C‐terminal domain with a large proportion of acidic residues. We characterized pKa values for all 26 sites in the protein that ionize below pH 7 using 2D 1H‐15N HSQC and 3D C(CO)NH NMR experiments. The N‐terminal domain shows systematically lowered pKa values, suggesting weak electrostatic interactions between acidic and basic residues in the KTKEGV repeats. By contrast, the C‐terminal domain shows elevated pKa values due to electrostatic repulsion between like charges. The effects are smaller but persist at physiological salt concentrations. For α‐synuclein in the membrane‐like environment of sodium dodecylsulfate (SDS) micelles, we characterized the pKa of His50, a residue of particular interest since it is flanked within one turn of the α‐helix structure by the Parkinson's disease‐linked mutants E46K and A53T. The pKa of His50 is raised by 1.4 pH units in the micelle‐bound state. Titrations of His50 in the micelle‐bound states of the E46K and A53T mutants show that the pKa shift is primarily due to interactions between the histidine and the sulfate groups of SDS, with electrostatic interactions between His50 and Glu46 playing a much smaller role. Our results indicate that the pKa values of uncomplexed α‐synuclein differ significantly from random coil model peptides even though the protein is intrinsically unfolded. Due to the long‐range nature of electrostatic interactions, charged residues in the α‐synuclein sequence may help nucleate the folding of the protein into an α‐helical structure and confer protection from misfolding.

1 July 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SJSuman Jha
Suman Jha
SPSharadrao M. Patil
Sharadrao M. Patil
JGJason Gibson
Jason Gibson
CNCraig E. Nelson
Craig E. Nelson
NANathan Alder
Nathan Alder
AAAndrei Alexandrescu
Andrei Alexandrescu
We characterized the interaction of amylin with heparin fragments of defined length, which model the glycosaminoglycan chains associated with amyloid deposits found in type 2 diabetes. Binding of heparin fragments to the positively charged N-terminal half of monomeric amylin depends on the concentration of negatively charged saccharides but is independent of oligosaccharide length. By contrast, amylin fibrillogenesis has a sigmoidal dependence on heparin fragment length, with an enhancement observed for oligosaccharides longer than four monomers and a leveling off of effects beyond 12 monomers. The length dependence suggests that the negatively charged helical structure of heparin electrostatically complements the positively charged surface of the fibrillar amylin cross-β structure. Fluorescence resonance energy transfer and total internal reflection fluorescence microscopy experiments indicate that heparin associates with amylin fibrils, rather than enhancing fibrillogenesis catalytically. Short heparin fragments containing two- or eight-saccharide monomers protect against amylin cytotoxicity toward a MIN6 mouse cell model of pancreatic β-cells.